Stuart Walter Peltz, Chief Executive Officer at PTC THERAPEUTICS, INC. (PTCT), sold 219,856 shares at $51.01 ($11.1M) on 2020-05-05, disclosed to the SEC on 2020-05-07.
Open-market sale of $11.1M PTCT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.33 | 107,943 | $5.4M | 49.1% |
| 2 | $50.33 | 107,943 | $5.4M | 49.1% |
| 3 | $51.01 | 1,985 | $101K | 0.9% |
| 4 | $51.01 | 1,985 | $101K | 0.9% |
| Total | $50.34 avg | 219,856 | $11.1M | 100% |
| Filing → |
| PTCT | SELL | 2023-01-12 | $257K | — | Filing → |
| PTCT | SELL | 2023-01-11 | $160K | — | Filing → |
| PTCT | SELL | 2022-06-09 | $11K | — | Filing → |